John H Johnson Insider Trading Transactions
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
Latest Insider Trading Transactions of John H Johnson
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Chief Executive Off ... | Payment of Exercise | F | 2.68 | 17,325 | 46,431 | 995,827 | 1 M to 995.8 K (-1.71 %) |
Jul 07 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Chief Executive Off ... | Grant | A | 0.00 | 315,000 | 0 | 522,152 | 207.2 K to 522.2 K (+152.06 %) |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | D | 0.00 | 54,991 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | D | 17.94 | 11,377 | 204,103 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 7,281 | 131,058 | 0 | 7.3 K to 0 (-100.00 %) |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 13,194 | 237,492 | 0 | 13.2 K to 0 (-100.00 %) |
Jun 18 2020 | VSTM | Verastem, Inc. | JOHNSON JOHN | Director | Option Exercise | A | 1.77 | 27,602 | 48,856 | 27,602 | |
Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 17.94 | 11,377 | 204,103 | 11,377 | |
Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 7,281 | 0 | 20,475 | 13.2 K to 20.5 K (+55.18 %) |
May 18 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Payment of Exercise | F | 2.86 | 15,348 | 43,895 | 207,152 | 222.5 K to 207.2 K (-6.90 %) |
May 18 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Payment of Exercise | F | 2.86 | 15,348 | 43,895 | 207,152 | 222.5 K to 207.2 K (-6.90 %) |
Apr 29 2020 | VSTM | Verastem, Inc. | JOHNSON JOHN | Director | Option Exercise | A | 1.81 | 25,000 | 45,250 | 25,000 | |
Apr 10 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Option Exercise | A | 1.90 | 87,500 | 166,250 | 87,500 | |
Apr 10 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Grant | A | 0.00 | 182,500 | 0 | 222,500 | 40 K to 222.5 K (+456.25 %) |
Nov 18 2019 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Option Exercise | A | 1.56 | 275,000 | 429,000 | 275,000 | |
Jul 02 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Chief Executive Off ... | Sell | S | 5.57 | 13,000 | 72,441 | 37,400 | 50.4 K to 37.4 K (-25.79 %) |
Jun 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | M | 0.00 | 50,000 | 0 | 350,000 | |
Jun 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Buy | M | 0.00 | 50,000 | 0 | 50,400 | 400 to 50.4 K (+12,500.00 %) |
Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 26.09 | 6,991 | 182,395 | 6,991 | |
Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 4,194 | 0 | 13,194 | 9 K to 13.2 K (+46.60 %) |
May 16 2019 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Feb 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Chief Executive Off ... | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
Oct 29 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Interim CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Oct 29 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Interim CEO | Option Exercise | A | 2.80 | 150,000 | 420,000 | 150,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
May 17 2018 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Director | Option Exercise | A | 7.75 | 40,000 | 310,000 | 40,000 | |
Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 10.30 | 10,000 | 103,000 | 0 | |
Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 16.23 | 20,000 | 324,600 | 0 | |
Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 13.92 | 30,000 | 417,600 | 0 | |
Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 5,130 | 92,340 | 0 | 5.1 K to 0 (-100.00 %) |
Feb 05 2018 | AVEO | AVEO PHARMACEUTICA ... | JOHNSON JOHN | Director | Option Exercise | A | 3.08 | 100,000 | 308,000 | 100,000 | |
Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 35.06 | 6,000 | 210,360 | 6,000 | |
Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jun 14 2017 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 60,000 | |
Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
Jan 05 2017 | CEMP | CEMPRA, INC. | JOHNSON JOHN | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
Jan 05 2016 | CEMP | CEMPRA, INC. | JOHNSON JOHN | Director | Option Exercise | A | 31.13 | 15,000 | 466,950 | 15,000 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 6.86 | 10,475 | 71,859 | 10,475 | |
Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 44.39 | 10,000 | 443,900 | 10,000 | |
Jun 02 2015 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | A | 16.23 | 20,000 | 324,600 | 50,000 | |
Nov 26 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | D | 31.90 | 350,000 | 11,165,000 | 0 | |
Nov 26 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | D | 0.00 | 23,610 | 0 | 0 | |
Nov 24 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Sell | U | 70.00 | 18,708 | 1,309,560 | 0 | 18.7 K to 0 (-100.00 %) |
Aug 28 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | M | 0.00 | 7,837 | 0 | 0 | |
Aug 28 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Payment of Exercise | F | 65.12 | 2,738 | 178,299 | 18,708 | 21.4 K to 18.7 K (-12.77 %) |
Aug 28 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Buy | M | 0.00 | 7,837 | 0 | 21,446 | 13.6 K to 21.4 K (+57.59 %) |
Sep 10 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Buy | P | 36.74 | 13,609 | 499,995 | 13,609 | 0 to 13.6 K |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 0.00 | 7,836 | 0 | 31,347 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 0.00 | 7,837 | 0 | 23,511 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 0.00 | 7,837 | 0 | 15,674 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 0.00 | 7,837 | 0 | 7,837 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 31.90 | 87,500 | 2,791,250 | 350,000 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 31.90 | 87,500 | 2,791,250 | 262,500 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 31.90 | 87,500 | 2,791,250 | 175,000 | |
Aug 29 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Johnson John H | CEO | Option Exercise | A | 31.90 | 87,500 | 2,791,250 | 87,500 |
Page: 1